SARA LAKDAWALA: Open Payments
NPI 1023660503 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$138 in 6 payments from 3 companies in 2025. Trend: 2023 $29 · 2024 $114 · 2025 $138
Food & beverage: $98Education: $40
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $60 |
| Astellas Pharma US Inc | 2 | $55 |
| ABBVIE INC. | 1 | $22 |
Products named: ZERBAXA, DALVANCE, Cresemba.
Industry payments across PA — which companies pay providers there.
